News Pfizer's antibody drug trial misses key survival target in A... Inotuzumab ozogamicin missed one of two endpoints in trial.
News Sanofi pushes on with Medivation takeover attempt French firm is attempting to oust Medivation's board.
ASCO-slider Eye on ASCO Day 4 - Moonshots, Money and Mobile apps You don't often get searched by the US secret service at a medical meeting.
Cancer IBM Watson to aid in patient matching with cancer clinical t... Froedtert & the Medical College of Wisconsin will use IBM Watson's Clinical Trial Matching to aid patient enrolment.
Cancer AbbVie/Janssen's blood cancer drug boosted by long-term data Extends survival regardless of line of therapy in CLL/SLL.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
